These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

152 related items for PubMed ID: 21139207

  • 1. High-level expression, purification, crystallization and preliminary X-ray crystallographic studies of the receptor-binding domain of botulinum neurotoxin serotype D.
    Zhang Y, Gao X, Qin L, Buchko GW, Robinson H, Varnum SM.
    Acta Crystallogr Sect F Struct Biol Cryst Commun; 2010 Dec 01; 66(Pt 12):1610-3. PubMed ID: 21139207
    [Abstract] [Full Text] [Related]

  • 2. Preliminary X-ray crystallographic study of the receptor-binding domain of the D/C mosaic neurotoxin from Clostridium botulinum.
    Nuemket N, Tanaka Y, Tsukamoto K, Tsuji T, Nakamura K, Kozaki S, Yao M, Tanaka I.
    Acta Crystallogr Sect F Struct Biol Cryst Commun; 2010 May 01; 66(Pt 5):608-10. PubMed ID: 20445271
    [Abstract] [Full Text] [Related]

  • 3. Crystal structure of the receptor binding domain of the botulinum C-D mosaic neurotoxin reveals potential roles of lysines 1118 and 1136 in membrane interactions.
    Zhang Y, Buchko GW, Qin L, Robinson H, Varnum SM.
    Biochem Biophys Res Commun; 2011 Jan 07; 404(1):407-12. PubMed ID: 21130733
    [Abstract] [Full Text] [Related]

  • 4. Cloning, high-level expression, single-step purification, and binding activity of His6-tagged recombinant type B botulinum neurotoxin heavy chain transmembrane and binding domain.
    Zhou Y, Singh BR.
    Protein Expr Purif; 2004 Mar 07; 34(1):8-16. PubMed ID: 14766296
    [Abstract] [Full Text] [Related]

  • 5. Structural insights into the functional role of the Hcn sub-domain of the receptor-binding domain of the botulinum neurotoxin mosaic serotype C/D.
    Zhang Y, Gardberg AS, Edwards TE, Sankaran B, Robinson H, Varnum SM, Buchko GW.
    Biochimie; 2013 Jul 07; 95(7):1379-85. PubMed ID: 23523511
    [Abstract] [Full Text] [Related]

  • 6. Crystallization and preliminary X-ray analysis of botulinum neurotoxin type A.
    Stevens RC, Evenson ML, Tepp W, DasGupta BR.
    J Mol Biol; 1991 Dec 20; 222(4):877-80. PubMed ID: 1762156
    [Abstract] [Full Text] [Related]

  • 7. Crystallization and preliminary crystallographic studies of the HA3 subcomponent of the type B botulinum neurotoxin complex.
    Nishimura K, Kitadokoro K, Takegahara Y, Sugawara Y, Matsumura T, Karatani H, Fujinaga Y.
    Acta Crystallogr Sect F Struct Biol Cryst Commun; 2011 Oct 01; 67(Pt 10):1244-6. PubMed ID: 22102038
    [Abstract] [Full Text] [Related]

  • 8. Crystallographic evidence for doxorubicin binding to the receptor-binding site in Clostridium botulinum neurotoxin B.
    Eswaramoorthy S, Kumaran D, Swaminathan S.
    Acta Crystallogr D Biol Crystallogr; 2001 Nov 01; 57(Pt 11):1743-6. PubMed ID: 11679763
    [Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11. Crystallization and preliminary X-ray analysis of Clostridium botulinum neurotoxin type B.
    Swaminathan S, Eswaramoorthy S.
    Acta Crystallogr D Biol Crystallogr; 2000 Aug 01; 56(Pt 8):1024-6. PubMed ID: 10944343
    [Abstract] [Full Text] [Related]

  • 12. Structural analysis of the catalytic and binding sites of Clostridium botulinum neurotoxin B.
    Swaminathan S, Eswaramoorthy S.
    Nat Struct Biol; 2000 Aug 01; 7(8):693-9. PubMed ID: 10932256
    [Abstract] [Full Text] [Related]

  • 13. Domain organization in Clostridium botulinum neurotoxin type E is unique: its implication in faster translocation.
    Kumaran D, Eswaramoorthy S, Furey W, Navaza J, Sax M, Swaminathan S.
    J Mol Biol; 2009 Feb 13; 386(1):233-45. PubMed ID: 19118561
    [Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15. Crystallization and preliminary X-ray analysis of the HA3 component of Clostridium botulinum type C progenitor toxin.
    Nakamura T, Tonozuka T, Kotani M, Obata K, Oguma K, Nishikawa A.
    Acta Crystallogr Sect F Struct Biol Cryst Commun; 2007 Dec 01; 63(Pt 12):1038-40. PubMed ID: 18084087
    [Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17. Immunoprecipitation of native botulinum neurotoxin complexes from Clostridium botulinum subtype A strains.
    Lin G, Tepp WH, Bradshaw M, Fredrick CM, Johnson EA.
    Appl Environ Microbiol; 2015 Jan 01; 81(2):481-91. PubMed ID: 25362065
    [Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19. Cocrystal structure of synaptobrevin-II bound to botulinum neurotoxin type B at 2.0 A resolution.
    Hanson MA, Stevens RC.
    Nat Struct Biol; 2000 Aug 01; 7(8):687-92. PubMed ID: 10932255
    [Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 8.